Curative Biotechnology (CUBT) Short Interest Ratio & Short Volume

Short interest is the volume of Curative Biotechnology shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,200 shares of CUBT short. Learn More on Curative Biotechnology's current short interest.

Curative Biotechnology saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,200 shares, an increase of 100.0% from the previous total of 600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Curative Biotechnology: Cryo-Cell International, Inc. (0.23%), BioRestorative Therapies, Inc. (2.61%), Pacific Health Care Organization, Inc. (0.04%), Mangoceuticals, Inc. (4.65%), Ontrak, Inc. (0.76%), NewGenIvf Group Limited (36.51%), Fresenius Medical Care AG (0.29%), DaVita Inc. (8.15%), Sotera Health (8.50%), Progyny, Inc. (8.81%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

Short selling CUBT is an investing strategy that aims to generate trading profit from Curative Biotechnology as its price is falling. CUBT shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Curative Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CUBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUBT, twice per month. The most recent reporting period available is April, 30 2025.